Clinical Trial Offers Minimally Invasive Procedure for Heart Valve Leak
Brigham and Women's Hospital (BWH) is currently participating in the nation-wide EVEREST II clinical trial for patients with a serious heart condition known as mitral regurgitation (MR), where blood leaks backward through the mitral valve with each heartbeat. MR forces the heart to work harder to circulate blood and can result in shortness of breath, fainting, low blood pressure, fluid retention, fatigue, loss of appetite and a hacking cough that worsens when lying down.
The trial features a minimally invasive mitral repair procedure using a MitraClip to close the hearts leaking valve and significantly improve blood flow to the heart and body.
Dr. Michael Davidson, one of the principle investigators on the trial and a cardiac surgeon at BWH explained, "Up to this point, surgery was the only option for patients with severe mitral regurgitation and this trial offers the chance to participate in a non-surgical method of repair.